Dearborn Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Buy |
12,000
+9,818
| +450% | +$2.71M | 0.16% | 80 |
|
|
2025
Q1 | $579K | Buy |
2,182
+670
| +44% | +$178K | 0.03% | 149 |
|
|
2024
Q4 | $351K | Buy |
1,512
+77
| +5% | +$17.9K | 0.01% | 198 |
|
|
2024
Q3 | $317K | Sell |
1,435
-2,453
| -63% | -$541K | 0.01% | 222 |
|
|
2024
Q2 | $764K | Sell |
3,888
-5
| -0.1% | -$983 | 0.03% | 134 |
|
|
2024
Q1 | $838K | Buy |
3,893
+610
| +19% | +$131K | 0.04% | 127 |
|
|
2023
Q4 | $691K | Buy |
3,283
+421
| +15% | +$88.7K | 0.03% | 140 |
|
|
2023
Q3 | $573K | Buy |
2,862
+1,152
| +67% | +$231K | 0.02% | 139 |
|
|
2023
Q2 | $317K | Buy |
1,710
+11
| +0.6% | +$2.04K | 0.01% | 184 |
|
|
2023
Q1 | $325K | Buy |
1,699
+7
| +0.4% | +$1.34K | 0.01% | 179 |
|
|
2022
Q4 | $285K | Buy |
1,692
+392
| +30% | +$65.9K | 0.01% | 198 |
|
|
2022
Q3 | $230K | Buy |
1,300
+11
| +0.9% | +$1.95K | 0.01% | 229 |
|
|
2022
Q2 | $264K | Sell |
1,289
-207
| -14% | -$42.4K | 0.01% | 220 |
|
|
2022
Q1 | $356K | Sell |
1,496
-200
| -12% | -$47.6K | 0.01% | 191 |
|
|
2021
Q4 | $387K | Buy |
1,696
+31
| +2% | +$7.07K | 0.01% | 193 |
|
|
2021
Q3 | $322K | Buy |
1,665
+5
| +0.3% | +$967 | 0.01% | 196 |
|
|
2021
Q2 | $353K | Sell |
1,660
-70
| -4% | -$14.9K | 0.01% | 187 |
|
|
2021
Q1 | $353K | Buy |
1,730
+537
| +45% | +$110K | 0.02% | 180 |
|
|
2020
Q4 | $217K | Buy |
+1,193
| New | +$217K | 0.01% | 241 |
|
|
2014
Q1 | – | Sell |
-2,554
| Closed | -$200K | – | 293 |
|
|
2013
Q4 | $200K | Sell |
2,554
-1,048
| -29% | -$82.1K | 0.02% | 296 |
|
|
2013
Q3 | $266K | Buy |
3,602
+112
| +3% | +$8.27K | 0.04% | 258 |
|
|
2013
Q2 | $265K | Buy |
+3,490
| New | +$265K | 0.04% | 254 |
|